+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Assisted Reproductive Technology Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904634
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The assisted reproductive technology market is undergoing dynamic transformation as new technologies, updated regulatory environments, and shifting patient care models reshape the competitive landscape. For senior decision-makers, anticipating these changes enables strategic planning and effective organizational alignment.

Market Snapshot: Assisted Reproductive Technology Market Growth

The assisted reproductive technology market expanded from USD 34.76 billion in 2025 to USD 40.94 billion in 2026, reflecting a compound annual growth rate (CAGR) of 18.11%. Projected figures suggest the market will reach USD 111.51 billion by 2032, driven by rapid global adoption of advanced fertility interventions and increased investment in reproductive health services.

Scope & Segmentation of the Assisted Reproductive Technology Market

This report provides a detailed, multidimensional analysis of the assisted reproductive technology sector, guiding leadership in opportunity capture and risk management throughout the value chain:

  • Procedural Techniques: Evaluates options including Gamete Intrafallopian Transfer, In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and Zygote Intrafallopian Transfer, supporting operational choices.
  • Cycle Modalities: Reviews fresh donor cycles, fresh non-donor cycles, and frozen cycles to foster process optimization and align care decisions with patient needs.
  • Treatment Modalities: Analyzes cryopreservation, embryo transfer, genetic testing, and oocyte retrieval to inform resourcing and impact quality outcomes across patient pathways.
  • End-User Settings: Covers ambulatory surgical centers, fertility clinics, and hospitals, each requiring distinct operational solutions and workflow strategies.
  • Product Categories: Assesses the role of consumables, equipment, media and reagents, and service support in facilitating laboratory and clinical advances.
  • Regions: Examines the Americas, Europe, Middle East & Africa, and Asia-Pacific, recognizing the implications of regional regulatory frameworks and diverse supply chain requirements.

Technologies such as digital health platforms, laboratory automation, genetic diagnostics, and integrated data systems set providers and suppliers apart, enabling tailored solutions according to the needs of each segment and region.

Key Takeaways for Senior Decision-Makers

  • Continuous advances in clinical and laboratory methods are expanding access and improving reliability in reproductive care, supporting the evolution of patient-centered service models.
  • Market consolidation and vertical integration are changing provider networks, impacting procurement and partnership structures at the regional level.
  • Data governance and robust quality assurance are increasingly necessary to meet regulatory standards and support secure collaboration in international contexts.
  • Implementation of digital technologies enhances patient engagement and enables more adaptive and remote service delivery models.
  • Detailed segmentation by procedure type, cycle option, and care setting informs focused product development and highlights new areas for operational improvement and strategic investment.
  • Differences in local regulation and reimbursement practices require organizations to adjust procurement and commercial strategies for each market.

Tariff Impact: Procurement Reconfiguration and Supply Chain Resilience

New tariffs on essential equipment and consumables are prompting organizations to reassess sourcing and supplier strategies across the assisted reproductive technology sector. Leading companies are responding by implementing several key measures:

  • Establishing robust inventory management through multi-year, risk-adjusted procurement practices to ensure supply continuity.
  • Pursuing nearshoring and regional partnerships to address increased import costs and navigate complex trade regulations.
  • Validating alternative components and expanding local manufacturing capacity for greater operational agility and compliance with region-specific requirements.
  • Enhancing collaboration with suppliers to secure dependable supply and reduce the impact of price fluctuations due to tariff changes.

Proactive procurement strategies and financial scenario planning are enabling stakeholders to improve operational resilience and optimize margins in response to ongoing market shifts and regulatory developments.

Methodology & Data Sources

The analysis is grounded in a robust mixed-methods approach, including structured interviews with laboratory and supply chain executives, systematic literature reviews, and examination of clinical and regulatory data sources. Rigorous expert validation and comprehensive data triangulation underpin the accuracy and reliability of these insights.

Why This Report Matters

  • Aligns organizational workflows across commercial, procurement, and clinical domains with proven best practices, fostering measurable improvements and continuous operational refinement.
  • Identifies actionable regional opportunities and risk variables, supporting informed market entry, product development, and partnership strategies.
  • Supports operational resilience planning, workforce upskilling, and adaptation to evolving regulatory and market conditions, ensuring readiness for emerging challenges.

Assisted Reproductive Technology Market: Strategic Imperatives

This report enables senior leaders to connect innovation with procurement and regional strategy. By leveraging targeted segmentation and technological insights, decision-makers can advance initiatives that yield improved patient outcomes and drive organizational efficiencies.

Conclusion

Equipped with this analysis, stakeholders can position their organizations for sustained growth and resilience in the evolving assisted reproductive technology market. Strategic integration of segmentation, procurement, and technology will support future competitiveness in reproductive health.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Assisted Reproductive Technology Market, by Product
8.1. Consumables
8.2. Equipment
8.3. Media And Reagents
8.4. Services
9. Assisted Reproductive Technology Market, by Technique
9.1. Gamete Intrafallopian Transfer
9.2. In Vitro Fertilization
9.2.1. Fresh Donor
9.2.2. Fresh Non-Donor
9.2.3. Frozen
9.3. Intracytoplasmic Sperm Injection
9.4. Intrauterine Insemination
9.5. Zygote Intrafallopian Transfer
10. Assisted Reproductive Technology Market, by Cycle Type
10.1. Fresh Donor
10.2. Fresh Non-Donor
10.3. Frozen
11. Assisted Reproductive Technology Market, by Treatment
11.1. Cryopreservation
11.2. Embryo Transfer
11.3. Genetic Testing
11.4. Oocyte Retrieval
12. Assisted Reproductive Technology Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Fertility Clinics
12.3. Hospitals
13. Assisted Reproductive Technology Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Assisted Reproductive Technology Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Assisted Reproductive Technology Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Assisted Reproductive Technology Market
17. China Assisted Reproductive Technology Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Bloom IVF Centre Ltd.
18.6. Boston IVF, LLC
18.7. Cook Medical Inc.
18.8. CReATe Fertility Centre Ltd.
18.9. Cryoport, Inc.
18.10. Esco Micro Pte. Ltd.
18.11. European Sperm Bank A/S
18.12. Ferring Pharmaceuticals B.V.
18.13. FUJIFILM Irvine Scientific, Inc.
18.14. Genea BIOMEDX Pty Ltd.
18.15. Hamilton Thorne, Inc.
18.16. INVO Bioscience, Inc.
18.17. IVFtech a.s.
18.18. Kitazato Corporation
18.19. LENUS Pharma GesmbH
18.20. Merck KGaA
18.21. Microm (UK) Ltd.
18.22. Monash IVF Group Ltd.
18.23. Ovascience, Inc.
18.24. Progyny, Inc.
18.25. Thermo Fisher Scientific Inc.
18.26. The Cooper Companies, Inc.
18.27. Vitrolife AB
18.28. Zita West Fertility Ltd.
List of Figures
FIGURE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MEDIA AND REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MEDIA AND REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EMBRYO TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EMBRYO TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EMBRYO TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OOCYTE RETRIEVAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OOCYTE RETRIEVAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OOCYTE RETRIEVAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 105. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 109. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 119. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 122. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 123. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 135. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 136. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 138. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 141. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 142. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 143. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 144. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 145. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 155. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 156. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 157. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 159. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 163. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 164. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 165. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 166. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 169. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 170. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 171. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 172. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 173. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 183. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 184. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 185. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2032 (USD MILLION)
TABLE 186. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2032 (USD MILLION)
TABLE 187. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
TABLE 188. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Assisted Reproductive Technology market report include:
  • Bloom IVF Centre Ltd.
  • Boston IVF, LLC
  • Cook Medical Inc.
  • CReATe Fertility Centre Ltd.
  • Cryoport, Inc.
  • Esco Micro Pte. Ltd.
  • European Sperm Bank A/S
  • Ferring Pharmaceuticals B.V.
  • FUJIFILM Irvine Scientific, Inc.
  • Genea BIOMEDX Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech a.s.
  • Kitazato Corporation
  • LENUS Pharma GesmbH
  • Merck KGaA
  • Microm (UK) Ltd.
  • Monash IVF Group Ltd.
  • Ovascience, Inc.
  • Progyny, Inc.
  • Thermo Fisher Scientific Inc.
  • The Cooper Companies, Inc.
  • Vitrolife AB
  • Zita West Fertility Ltd.

Table Information